---
title: "Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293238010.md"
description: "Tempus AI has committed to acquiring cancer diagnostics company Personalis for $1.5 billion, with the announcement made on Monday. However, the stocks of both medical technology firms experienced a decline in value following the news. This acquisition marks a significant move in the industry, emphasizing Tempus AI's strategic expansion efforts."
datetime: "2026-07-20T16:03:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293238010.md)
  - [en](https://longbridge.com/en/news/293238010.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293238010.md)
---

# Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive

Tempus AI has committed to acquiring cancer diagnostics company Personalis for $1.5 billion, with the announcement made on Monday. However, the stocks of both medical technology firms experienced a decline in value following the news. This acquisition marks a significant move in the industry, emphasizing Tempus AI's strategic expansion efforts.

### Related Stocks

- [PSNL.US](https://longbridge.com/en/quote/PSNL.US.md)
- [TEM.US](https://longbridge.com/en/quote/TEM.US.md)
- [TEMT.US](https://longbridge.com/en/quote/TEMT.US.md)

## Related News & Research

- [Tempus AI (TEM) Drops on $1.7B Personalis Deal; Needham Analyst Calls the Slide a "Market Misread"](https://longbridge.com/en/news/293251564.md)
- [TEM: A $1.5B acquisition merges AI oncology and MRD tech to lead in cancer monitoring](https://longbridge.com/en/news/293215484.md)
- [Tempus AI agrees to buy Personalis for USD 16.25 per share in USD 1.5 billion deal](https://longbridge.com/en/news/293214621.md)
- [Tempus AI delivered on Q1 2026, but the momentum question remains](https://longbridge.com/en/news/292936640.md)
- [TEM: $1.5B acquisition combines MRD portfolios to drive growth, data synergies, and profitability by 2027](https://longbridge.com/en/news/293238275.md)